April 21 (Reuters) - EC Healthcare 2138.HK :
* OPTIMISTIC ABOUT ITS BUSINESS PERFORMANCE
* GROUP EXPECTS TO RECORD SALES VOLUME OF NO LESS THAN
HK$3,000
MILLION FOR FY 2022
* CONSIDERS GROUP WILL BENEFIT FROM STRONG DEMAND AFTER
BUSINESS
REOPENING
* FULL YEAR OVERALL SALES VOLUME UP 35%
* EXPECTS AN INCREASE IN SALES VOLUME OF MEDICAL SERVICES IN
HONG
KONG OF NO LESS THAN 25% FOR SECOND HALF OF FY22
* EXPECTS INCREASE IN SALES VOLUME OF AESTHETIC MEDICAL AND
BEAUTY
SERVICES IN HONG KONG AND MACAU OF NO LESS THAN 5% FOR H2 FY22
* EXPECTS INCREASE IN SALES VOLUME IN CLINICS AND SERVICE
CENTERS
IN MAINLAND CHINA OF NO LESS THAN 8% FOR H2 FY22
Further company coverage: 2138.HK
((Reuters.Briefs@thomsonreuters.com;))